Xconomy Forum: San Diego’s Fight Against Diabesity
Thursday, January 27, 2011 at 6:00 PM (PST)
San Diego, CA
An estimated two-thirds of all Americans are now overweight or obese, and about 25 million people have chronic Type 2 diabetes that’s often caused by unhealthy diets and a lack of exercise. Taken together, these two related conditions are sometimes called “diabesity,” a shorthand term for a public health scourge that gives rise to other chronic diseases like arthritis, cardiovascular disease, and depression. Anyone who develops drugs to safely help people lose weight and control blood sugar has a clear opportunity to tap into a monster potential market, and save the health system billions of dollars.
San Diego’s biotech cluster happens to have core strength in this field, from well-known public companies like Amylin Pharmaceuticals, Orexigen Therapeutics, and Arena Pharmaceuticals to a new wave of startups. Yet the time and expense of diabetes and obesity drug development has been skyrocketing lately, as the FDA has raised the bar ever higher for new drug approvals in the wake of high-profile safety controversies with drugs like GlaxoSmithKline’s Avandia and Abbott Laboratories’ Meridia. We will convene San Diego’s leading entrepreneurs and investors who despite these higher barriers remain committed to finding ways to help the U.S. better manage this long-term threat to public health and wellbeing.
- Dan Bradbury, CEO, Amylin Pharmaceuticals
- Jack Lief, CEO, Arena Pharmaceuticals
- Kurt Graves, Executive Chairman, Intarcia
- John "Chip" Scarlett, Executive Chairman, Vega Therapeutics
- Bob More, General Partner, Frazier Healthcare Ventures
- Mike Powell, General Partner, Sofinnova Ventures
- Pratik Shah, Partner, Thomas, McNerney & Partners
- John West, CEO, ViaCyte
- Jeff Purvin, CEO, Calibra Medical
- Paul Laikind, Chief Business Officer, Sanford-Burnham Medical Research Institute
- Chrysa Mineo, Vice President, Corporate Development, Receptos
Bonus Demos Featured at the Networking Reception
- DPS Health
- Freedom Meditech
Registration: 5:15 - 6:00 pm
Program: 6:00 - 7:15 pm
Networking: 7:15 - 8:15 pm
Alexandria Real Estate Equities · AMRI · Biogen Idec · Invest Northern Ireland
J. Robert Scott · Kauffman Foundation · Latham & Watkins · Morrison & Foerster
Science and Technology Directorate, U.S. Department of Homeland Security
BIOCOM · CleanTECH San Diego · CommNexus San Diego · CONNECT
San Diego Software Industry Council · San Diego Venture Group
VENTURE CAPITAL MEMBER
When & Where
Xconomy is an innovative news and events organization with outposts in Boston, Boulder/Denver, Detroit, New York, San Diego, San Francisco, Seattle, and Texas. It is dedicated to providing business and technology leaders with timely, insightful, close-to-the-scene information about the local personalities, companies, and technological trends that best exemplify today’s high-tech economy. Xconomy is staffed by world-class journalists and media professionals, and supported by “the Xconomists,” who include some of the world’s leading innovators. Get to know them and the Xconomy team at www.xconomy.com/about.
Sign up for RSS feeds, daily email newsletters, and email alerts from Xconomy at http://www.xconomy.com/rss-feeds/.